Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort studyCraig Haifer, Lena Thin, Daniel R. van Langenberg et al.|UWA Profiles and Research Repository (University of Western Australia)|2019Cited by 3